BSE filing, NSE: SCTL. Summary written from the filing by ALFA Finder's alert engine.
Suncare Traders Ltd: key numbers
- Share price
- ₹0.40
- Market cap
- ₹10.20 Cr
- Revenue (annual)
- ₹0.00 Cr
- Net profit (annual)
- ₹0.66 Cr
- P/E (TTM)
- -5.5×Sector 36.4×
- Promoter holding
- 4.69%+0.00% QoQ
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Suncare Traders Ltd
All →Suncare Traders Board Meeting Date
Suncare Traders Limited intimated a board meeting on 3 November 2026 to consider unaudited financial results for the quarter and half year ended 30 September 2026. The agenda is proposed only and the meeting has not yet been held.
Suncare Traders Annual General Meeting
Suncare Traders Limited concluded its 29th Annual General Meeting on September 29, 2026. Shareholders approved the annual financial statements and the appointment of Mr. Ramesh Salvi.
Suncare Traders Annual Report
Suncare Traders Limited has submitted its Annual Report for the financial year 2025-26. The 29th Annual General Meeting is scheduled for September 29, 2026.
Suncare Traders Annual General Meeting
Suncare Traders Limited has issued a notice for its 29th Annual General Meeting on September 29, 2026. The agenda includes appointing Mr. Ramesh Salvi as Whole Time Director.
Suncare Traders Management Change
Suncare Traders Limited appointed Ramesh Salvi as Wholetime Director and CFO, following the resignation of Harshad Rathod from these roles, effective July 21, 2026.
Suncare Traders Q1 FY27 Results: Net Profit ₹0.3 Cr, Down 70.0% YoY
Suncare Traders Ltd reported revenue from operations of ₹0.5 Cr (-54.5% YoY) and net profit of ₹0.3 Cr (-70.0% YoY) for Q1 FY27.
- Key figure
- Net profit ₹0.3 Cr · -70.0% YoY
Other other announcement announcements
All →Aarti Pharmalabs Other Announcement
Aarti Pharmalabs has intimated under Regulation 46 that it revamped its website at the existing URL to improve design and accessibility. The notice has no financial or business substance.
Sagarsoft (India) Other Announcement
Sagarsoft (India) filed its Regulation 32 fund utilisation statement for its 2021 preferential issue. No deviation was reported and the full Rs.5.08 Crore was used.
Sadhana Nitro Chem Other Announcement
Sadhana Nitro Chem reported no deviation in use of its preferential issue proceeds for the quarter ended September 2026. The Audit Committee reviewed the statement.
Shriram Asset Management Company Other Announcement
Shriram AMC filed ICRA's quarterly monitoring agency report on preferential issue proceeds. Utilisation is in line with the offer objects, with no deviation reported.
Jhandewalas Foods Other Announcement
Jhandewalas Foods filed its quarterly shareholding pattern for the period ended September 30, 2026. The filing records holdings by category and contains no transaction or money event.
Avience Biomedicals Other Announcement
Avience Biomedicals confirmed corporate governance compliance is not applicable, as it is SME-listed on NSE Emerge. No quarterly governance report is required for September 2026.